logo

JANX

Janux Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

JANX fundamentals

Janux Therapeutics (JANX) released its earnings on Aug 7, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.55 (YoY -400.00%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.55
-400.00%
Report date
Aug 7, 2025
EPS
Revenue

Revenue & Expenses

JANX has released its 2025 Q3 earnings report, with revenue of 10.00M, reflecting a YoY change of 2177.90%, and net profit of -24.31M, showing a YoY change of 13.35%. The Sankey diagram below clearly presents JANX's revenue sources and cost distribution.

Key Indicators

Janux Therapeutics (JANX) key financial stats and ratios, covering profitability, financial health, and leverage.
Janux Therapeutics (JANX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Janux Therapeutics (JANX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Janux Therapeutics (JANX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Janux Therapeutics (JANX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Janux Therapeutics (JANX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield